NCT06850116Active, not recruiting
Analysis of Immediate Urinary Continence Predictors After RS-RARP
Analysis of Immediate Urinary Continence Predictors After Retzius-sparing Robot-assisted Radical Prostatectomy: A Single-center Retrospective Clinical Study
Source: ClinicalTrials.gov · Last updated 4 Apr 2025
Brief summary (registry, in English)
This study is a retrospective, single-center clinical trial. It aims to retrospectively analyze the immediate postoperative urinary continence recovery in prostate cancer patients who underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' center. Based on the general conditions of patients, relevant perioperative clinical indicators, and parameters related to the sphincter and prostate gland measured by MRI, it explores the influencing factors of immediate urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in prostate cancer patients and constructs a relevant prediction model, thereby providing clinical guidance value for predicting immediate postoperative urinary continence recovery.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 24 Feb 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- First Affiliated Hospital of Fujian Medical University
- Diseases
- Prostate cancer, Childhood cancers
- NCT number
- NCT06850116
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Jan 2025 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient has surgical contraindications.
- Preoperative presence of congenital urinary system malformations, urinary incontinence or severe lower urinary tract symptoms, and with a history of urinary catheter or previous transurethral resection of the prostate (TURP) surgery.
- Having received neoadjuvant treatments that may affect the results of this study, such as radiotherapy or hormonal therapy.
- The patient has other concurrent malignant tumors.
Other
- The patient has contraindications for MRI examination.
- The patient has delayed extubation (\> 14 days).
- The patient's clinical, imaging and pathological data are incomplete or the patient is lost to follow-up.
Who the study is looking for
- Prostate cancer diagnosed by prostate biopsy and underwent Retzius-sparing robot-assisted radical prostatectomy in the investigators' hospital.
- Received plain and contrast-enhanced pelvic or prostate MRI examinations before surgery.
- Eastern Cooperative Oncology Group (ECOG) performance status score between 0 and 1.
- Complete clinicopathological data.
- In good general condition, without infections, autoimmune diseases, hematological diseases or other malignant tumors.
- Complete postoperative follow-up data, with a postoperative follow-up time of no less than 6 months.
Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| first hospital affiliated of Fujian medical university Coordinator of this site? Confirm its status | Fuzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.